Roche leads Flatiron's $175M round
Healthcare IT company Flatiron Health Inc. (New York, N.Y.) secured $175 million in a series C round led by Roche (SIX:ROG; OTCQX:RHHBY). Other investors include Allen & Co., Baillie Gifford and Casdin Capital. Flatiron said it plans to further invest the new funds in its OncologyCloud web-based data integration platform, which includes analytics tool OncoAnalytics and OncoEMR, a cancer-specific electronic medical record system.
Flatiron also said it will enter a multi-year, non-exclusive deal with Roche under which the pharma will purchase Flatiron life science offerings. Flatiron said the companies also will "collaborate to accelerate clinical trials, advance personalized medicine and enhance patient care," but declined to provide details. ...